Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
55°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
99
100
Next >
FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease
April 01, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
APLT
Rehab Explains Reasons to Increase Suboxone Dose
April 01, 2024
Via
Press Advantage
Exposures
Product Safety
FDA Again Pursues Ban on Behavioral Electroshock Device
April 01, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 31, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 31, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, A LEADING NATIONAL FIRM, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 30, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, A LEADING NATIONAL FIRM, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 30, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 29, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 29, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
Second Chance For Nikola? Electric Trucks Return To Customers After Fire Recalls With New Features
March 29, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
NKLA
BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference
March 28, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
TinyGemsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference
March 28, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia
March 28, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AKBA
Medicus Pharma says U.S. FDA has provided comments on Phase 2 Clinical Protocol of SKNJCT-003
March 28, 2024
Via
News Direct
Exposures
Product Safety
Medicus Pharma says U.S. FDA has provided comments on Phase 2 Clinical Protocol of SKNJCT-003
March 28, 2024
Via
TheNewswire.com
Exposures
Product Safety
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
ABBV
ALEC
ALNY
BIIB
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK
March 28, 2024
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Product Safety
Securities Market
Tickers
ASX:MSB
DYAI
INBS
MESO
Merck Stock Soars On FDA Approval for Winrevair: Technical Analysis And Market Outlook
March 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
MRK
Medtronic's Latest Generation Of Transcatheter Aortic Valve Replacement Implant Passes FDA's Muster, Shares Gain
March 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
MDT
InvestorNewsBreaks – Beyond Air Inc. (NASDAQ: XAIR) Reports on $16M Registered Direct Offering with Health-Care Focused Investors
March 27, 2024
Via
Investor Brand Network
Exposures
COVID-19
Product Safety
Tickers
XAIR
Supreme Court Signals Unlikelihood of Restricting Abortion Pill Access, Questions Legal Standing
March 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
CVS
WBA
Ondine Biomedical achieves milestone with NHS trust's adoption of Steriwave
March 27, 2024
Via
News Direct
Exposures
Product Safety
Ondine Biomedical achieves milestone with NHS trust's adoption of Steriwave
March 27, 2024
Via
TheNewswire.com
Exposures
Product Safety
Merck's $11B Bet Pays As FDA Approves Sotatercept For Rare Lung Disease
March 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
MRK
Merck's Cardiovascular 'Renaissance' Is Here With The First Approval Of A $10 Billion Franchise
March 26, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
MRK
Upcoming Stock Dividend Coupled with Approved Share Structure Reduction Intended to Counter Short Selling and Boost Institutional Investment, Key Company Presentation Coming Up in UK: NRXP
March 26, 2024
Via
Get News
Exposures
Product Safety
After Almost 4 Years, FDA Says Mesoblast Phase 3 Therapy Data Can Support Resubmission For Serious Complications in Children Following Stem Cell Transplant
March 26, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ASX:MSB
MESO
Elon Musk-Backed Brain Chip Implant Neuralink Under Scrutiny Lens Following FDA's Oversight Regulatory Compliance
March 26, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AIEQ
BKES
QRFT
ROBO
Tung Sin Biomedical EYESBRIGHT Obtains U.S. Food and Drug Administration (FDA) Import Approval, Set to Launch on Amazon to Seize North American Opportunities
March 26, 2024
Via
MerxWire
Exposures
Product Safety
Tickers
AMZN
PRISM MarketView Previews Anticipated FDA Drug Approvals for 2024
March 25, 2024
Via
AB Newswire
Exposures
COVID-19
Product Safety
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.